Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma

Digestive Diseases and Sciences

Volumn 56, Issue 12, 2011, Pages 3569-3576

  Zhu, Shaojun ^a   Li, Yanhong ^a   Mi, Li ^b   Zhang, Yang ^b   Zhang, Li ^a   Gong, Li ^a   Han, Xiujuan ^a   Yao, Li ^a   Lan, Miao ^a   Chen, Zhinan ^b   Zhang, Wei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ESCC; HAb18G CD147; Immunohistochemistry; Survival

Indexed keywords

CD147 ANTIGEN; MESSENGER RNA; BSG PROTEIN, HUMAN; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER TISSUE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; WESTERN BLOTTING; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE COURSE; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; AGED; ANTIGENS, CD147; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 84856133948     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1812-x     Document Type: Article

References (40)

1. Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis. 2001;22:1737-1746. (Pubitemid 33064837)
2. Stoner GD, Rustgi AK. Biology of the esophageal squamous cell carcinoma. Gastrointest Cancers Biol Diagn. 1995;8:141-146.
3. WHO. The World Health Report 1997-conquering suffering, enriching humanity. World Health Forum. 1997;18:248-260.
4. Reed CE. Surgical management of esophageal carcinoma. Oncologist. 1999;4:95-105. (Pubitemid 29202994)
5. De LL, Curia MC, Aceto GM, et al. Analysis of extended genomic rearrangements in oncological research. Ann Oncol. 2007;18:173-178.
6. Biswas C, Zhang Y, DeCastro R, et al. The human tumor cellderived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995;55:434-439.
7. Tang W, Chang SB, Hemler ME. Links between CD147 function, glycosylation, and caveolin-1. Mol Biol Cell. 2004;15:4043-4050. (Pubitemid 39122010)
8. Yan L, Zucker S, Toole BP, et al. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost. 2005;93:199-204. (Pubitemid 40253722)
9. Kirk P, Wilson MC, Heddle C, et al. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 2000;19:3896-3904. (Pubitemid 30608530)
10. Xu D, Hemler ME. Metabolic activation-related CD147-CD98 complex. Mol Cell Proteomics. 2005;4:1061-1071. (Pubitemid 41223366)
11. Berditchevski F, Chang S, Bodorova J, et al. Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6. J Biol Chem. 1997;272:29174-29180. (Pubitemid 27498208)
12. Curtin KD, Meinertzhagen IA, Wyman RJ. Basigin (EMMPRIN/ CD147) interacts with integrin to affect cellular architecture. J Cell Sci. 2005;118:2649-2660. (Pubitemid 40932890)
13. Gordon JM, Bauer EA, Eisen AZ. Collagenase in human cornea: immunologic localization. Arch Ophthalmol. 1980;98:341-345. (Pubitemid 10129389)
14. Wagoner MD, Kenyon KR. Distribution of collagenase and cell types in sterile ulceration of human corneal grafts. Acta Ophthalmol. 1989;192:65-71. (Pubitemid 19223746)
15. Major TC, Liang L, Lu X, Rosebury W, Bocan TM. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler Thromb Vasc Biol. 2002;22:1200-1207. (Pubitemid 34764874)
16. Li Z, Ren Y, Wu QC, et al. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrixmetalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. J Chin Med. 2004;117:107-114. (Pubitemid 38240242)
17. Zucker S, Hymowitz M, Rollo EE, et al. Tumorigenic potential of extracellular matrixmetalloproteinase inducer. Am J Pathol. 2001;158:1921-1928. (Pubitemid 32545174)
18. Ramos-Simone N, Hahn-Dantona E, Sipley J, et al. Activation of matrix metalloprotease-9 (MMP-9) via a converting plasmin/ stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem. 1999;274:13066-13076.
19. Davidson B, Goldberg I, Berner A, et al. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clin Exp Metastasis. 2003;20:161-169. (Pubitemid 36403281)
20. Guo H, Li R, Zucker S, et al. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res. 2000;60:888-891. (Pubitemid 30129521)
21. Bourguignon L, Gunja-Smith Z, Iida N, et al. CD44v (3, 8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol. 1998;176:206-215. (Pubitemid 28277210)
22. Li Z, Ren Y, Wu QC, et al. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. Chin Med J. 2004;117:107-114. (Pubitemid 38240242)
23. Tang J, Zhou HW, Jiang JL, et al. βig-h3 is involved in the CD147/CD147-mediated metastasis process in human hepatoma cells. Exp Biol Med. 2007;232:344-352. (Pubitemid 46334050)
24. Cheng MF, Tzao C, Tsai WC, et al. Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. Dis Esophagus. 2006;19:482-486. (Pubitemid 44644686)
25. Tang J, Wu YM, Zhao P, Yang XM, Jiang JL, Chen ZN. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3KCa2? pathways. Cell Mol Life Sci. 2008;65:2933-2942.
26. Iwasa S, Okada K, Chen WT, et al. Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett. 2003;199:91-98. (Pubitemid 37088142)
27. Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer. 2001;95:67-72.
28. Caudroy S, Polette M, Tournier JM, et al. Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. J Histochem Cytochem. 1999;47:1575-1580.
29. Polette M, Gilles C, Marchand V, et al. Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J Histochem Cytochem. 1997;45:703-709. (Pubitemid 27224703)
30. Bordador LC, Li X, Toole B, et al. Expression of EMMPRIN by oral squamous cell carcinoma. Int J Cancer. 2000;85:347-352. (Pubitemid 30030407)
31. Thorns C, Feller AC, Merz H. EMMPRIN (CD 174) is expressed in Hodgkin's lymphoma and anaplastic large cell lymphoma. An immunohistochemical study of 60 cases. Anticancer Res. 2002;22:1983-1986. (Pubitemid 34857013)
32. Gabison EE, Huet E, Baudouin C, Menashi S. Direct epithelialstromal interaction in corneal wound healing: Role of EMMPRIN/ CD147 in MMPs induction and beyond. Prog Retin Eye Res. 2009;28:19-33.
33. Yu W, Liu J, Xiong X, Ai Y, Wang H. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathol Res Pract. 2009;205:709-715.
34. Riethdorf S, Reimers N, Assmann V, et al. High incidence of EMMPRIN expression in human tumors. Int J Cancer. 2006;119:1800-1810. (Pubitemid 44356836)
35. Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int. 2006;56:359-367. (Pubitemid 43886799)
36. Tang Y, Kesavan P, Nakada MT, Yan L. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res. 2004;2:73-80. (Pubitemid 38250423)
37. Moll UM, Lane B, Zucker S, Suzuki K, Nagase H. Localization of collagenase at the basal plasma membrane of a human pancreatic carcinoma cell line. Cancer Res. 1990;50:6995-7002. (Pubitemid 20361104)
38. Caudroy S, Polette M, Nawrocki-Raby B, et al. EMMPRINmediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis. 2002;19:697-702. (Pubitemid 36092265)
39. Menashi S, Serova M, Ma L, Vignot S, Mourah S, Calvo F. Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res. 2003;63: 7575-7580. (Pubitemid 37466675)
40. Qian AR, Zhang W, Cao JP, et al. Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2008;27:50.